Raounak Drugs Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2014.
2014 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Raounak Drugs Private Limited

Raounak Drugs Private Limited, a active private limited company, was established on 31 March 2014 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33111MP2014PTC032643. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.30 Cr.

It upholds a compliant status. Its leadership includes Aniruddha Deharia (Director), Tulasiram Dehariya (Director), Sanjeev Tiwari (Whole-Time Director). Past directors included Gunasheela Gangadhar Uppin, Gangadhar Chandrashekar Uppin, Sanjeev Tiwari. It holds ₹5.32 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Office No. 102, 01St Floor, Harshdeep Avenue 157, Chikitsak Nagar, Satya Sai, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33111MP2014PTC032643

  • Registration Number

    032643

  • Incorporation Date

    31 March 2014

  • Authorized Capital

    ₹1.30 Cr

  • Paid-Up Capital

    ₹1.30 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.30 Cr
  • Paid Up Capital ₹ 1.30 Cr
  • Company Age 11 Year, 11 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 5.32 Cr
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth 0.26%
  • Total Assets **** 80.57%
Company report

Raounak Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raounak Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Raounak Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Aniruddha Deharia Director 21 Mar 2022 Current
Tulasiram Dehariya Director 21 Mar 2022 Current
Sanjeev Tiwari Whole-Time Director 31 Mar 2014 Current
Alok Lashkari Additional Director 03 Dec 2019 Current
Rajesh Kumar Sharma Managing Director 09 Jan 2016 Current
Shraddha Tiwari Director 23 May 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 May 2015 Past
Pramod Abcsdd Director 23 May 2015 Past
Pramod Abcsdd Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raounak Drugs.

Raounak Drugs Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.26%.

Raounak Drugs revenue growth over time
Raounak Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 80.57%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 0.26%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raounak Drugs?

In 2019, Raounak Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹53,177,019.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 5.32 Cr
Latest Charge Details
Date Lender Amount Status
17 Jan 2025 Others ₹5.18 M Open
29 Oct 2021 Others ₹8.00 M Open
21 Aug 2017 Others ₹4.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Raounak Drugs?

Unlock and access historical data on people associated with Raounak Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raounak Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raounak Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raounak Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 0.52 Cr with Charge ID 101083883 was registered on 17 Jan 2025. was documented.

  • Director Appointment

    Progress on Aniruddha Deharia was appointed as a Director was appointed as a Director on 21 Mar 2022 & has been associated with this company since 3 years 11 months . was documented.

  • Director Appointment

    Progress on Tulasiram Dehariya was appointed as a Director was appointed as a Director on 21 Mar 2022 & has been associated with this company since 3 years 11 months . was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.80 Cr with Charge ID 100521153 was registered on 29 Oct 2021. was documented.

  • Director Appointment

    The activity Alok Lashkari was appointed as a Additional Director was appointed as a Additional Director on 03 Dec 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Annual General Meeting

    The activity Raounak Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raounak Drugs Private Limited?

The CIN of Raounak Drugs Private Limited is U33111MP2014PTC032643.

Where is Raounak Drugs Private Limited headquartered?

Raounak Drugs Private Limited is headquartered at Office No. 102, 01St Floor, Harshdeep Avenue 157, Chikitsak Nagar, Satya Sai, Indore, Madhya Pradesh, 452010.

When was Raounak Drugs Private Limited incorporated?

Raounak Drugs Private Limited was incorporated on 31 March 2014.

Who are the current directors of Raounak Drugs Private Limited?

The current directors of Raounak Drugs Private Limited are

What is the primary industry of Raounak Drugs Private Limited?

The primary industry of Raounak Drugs Private Limited is Pharma.

Is Raounak Drugs Private Limited a listed company?

Raounak Drugs Private Limited is unlisted.

What is the capital structure of Raounak Drugs Private Limited?

The authorized capital of Raounak Drugs Private Limited is ₹1.30 Cr, and the paid-up capital is ₹1.30 Cr.

What is the compliance status of Raounak Drugs Private Limited?

The compliance status of Raounak Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available